Helen Kalirai Selected Research

Helen Kalirai Research Topics

Disease

24	Uveal melanoma 06/2023 - 01/2010
14	Neoplasms (Cancer) 01/2023 - 08/2006
14	Melanoma (Melanoma, Malignant) 06/2020 - 01/2010
7	Neoplasm Metastasis (Metastasis) 06/2023 - 01/2017
5	Monosomy 01/2023 - 01/2010
2	Hypoxia (Hypoxemia) 01/2023 - 01/2023
2	Colorectal Neoplasms (Colorectal Cancer) 11/2010 - 09/2010
1	Retinoblastoma (Glioblastoma, Retinal) 11/2021
1	Disease Progression 08/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 05/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2012
1	Proliferative Vitreoretinopathy 01/2012
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2012
1	Rectal Neoplasms (Rectal Cancer) 11/2010
1	Colonic Neoplasms (Colon Cancer) 11/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2010
1	Osteosarcoma (Osteogenic Sarcoma) 08/2006

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2010
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2010
4	Formaldehyde (Formol)FDA Link 01/2018 - 01/2010
3	Protons (Proton)IBA 10/2020 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 05/2012
3	ParaffinIBA 01/2018 - 01/2010
2	Perilipin-2IBA 01/2023 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2023
2	ProteomeIBA 07/2021 - 01/2012
2	Bleomycin (Blenoxane)FDA LinkGeneric 06/2020 - 06/2019
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 03/2011
2	HSP27 Heat-Shock ProteinsIBA 09/2012 - 11/2010
1	alvocidib (flavopiridol)IBA 06/2023
1	Everolimus FDA Link 06/2023
1	quisinostatIBA 06/2023
1	navitoclaxIBA 06/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Carvedilol (Coreg)FDA LinkGeneric 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2023
1	LipidsIBA 01/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2023
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2023
1	RetinoidsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 12/2022
1	GTP-Binding Proteins (G-Protein)IBA 12/2022
1	Messenger RNA (mRNA)IBA 12/2022
1	Dual-Specificity PhosphatasesIBA 12/2022
1	LactoferrinIBA 11/2021
1	Etoposide (VP 16)FDA LinkGeneric 11/2021
1	Carboplatin (JM8)FDA LinkGeneric 11/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2021
1	AS 8IBA 10/2020
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 10/2020
1	MicroRNAs (MicroRNA)IBA 08/2020
1	Protein Kinases (Protein Kinase)IBA 05/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	EnzymesIBA 01/2020
1	A-Form DNA (A-DNA)IBA 01/2020
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 06/2019
1	Fluorouracil (Carac)FDA LinkGeneric 06/2019
1	NestinIBA 08/2018
1	Ruthenium-106IBA 07/2014
1	RutheniumIBA 07/2014
1	Therapeutic UsesIBA 05/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2010
1	Indicators and Reagents (Reagents)IBA 11/2010
1	ChemokinesIBA 09/2010
1	Calgranulin AIBA 09/2010
1	VimentinIBA 01/2010
1	AntigensIBA 01/2010
1	EmeticsIBA 08/2006
1	GlucocorticoidsIBA 08/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2006
1	Cisplatin (Platino)FDA LinkGeneric 08/2006

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2017
4	Ligation 10/2015 - 01/2010
3	Aftercare (After-Treatment) 02/2020 - 05/2014
2	Drug Therapy (Chemotherapy) 06/2023 - 10/2011
2	Immunotherapy 06/2023 - 01/2020
2	Brachytherapy 10/2020 - 07/2014
1	Transplantation 01/2023
1	Life Support Care 04/2022
1	Metastasectomy 04/2022
1	Radiotherapy 10/2020
1	Proton Therapy 10/2016
1	Nephrectomy 04/2012
1	Neoadjuvant Therapy 11/2010